Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021

SELL
$114.63 - $133.34 $12.1 Million - $14.1 Million
-105,543 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$112.7 - $128.05 $1.26 Million - $1.43 Million
-11,183 Reduced 9.58%
105,543 $12.6 Million
Q3 2020

Nov 03, 2020

SELL
$107.05 - $130.01 $2.99 Million - $3.63 Million
-27,956 Reduced 19.32%
116,726 $13.4 Million
Q2 2020

Aug 06, 2020

SELL
$73.34 - $122.61 $6.89 Million - $11.5 Million
-93,905 Reduced 39.36%
144,682 $16.5 Million
Q1 2020

May 05, 2020

BUY
$75.14 - $115.68 $8.18 Million - $12.6 Million
108,821 Added 83.86%
238,587 $19.2 Million
Q4 2019

Feb 10, 2020

SELL
$100.29 - $107.99 $3.5 Million - $3.77 Million
-34,945 Reduced 21.22%
129,766 $13.9 Million
Q3 2019

Nov 07, 2019

SELL
$97.85 - $107.42 $430,931 - $473,077
-4,404 Reduced 2.6%
164,711 $17.6 Million
Q2 2019

Aug 06, 2019

SELL
$85.18 - $101.94 $3.37 Million - $4.03 Million
-39,548 Reduced 18.95%
169,115 $17.2 Million
Q1 2019

May 07, 2019

SELL
$80.68 - $89.92 $5.99 Million - $6.68 Million
-74,287 Reduced 26.25%
208,663 $18.8 Million
Q4 2018

Feb 08, 2019

BUY
$79.75 - $108.38 $625,638 - $850,241
7,845 Added 2.85%
282,950 $23.6 Million
Q3 2018

Nov 09, 2018

SELL
$105.42 - $114.99 $8.57 Million - $9.35 Million
-81,289 Reduced 22.81%
275,105 $29.7 Million
Q1 2018

May 10, 2018

SELL
$96.42 - $107.88 $1.36 Million - $1.52 Million
-14,074 Reduced 3.8%
356,394 $35.7 Million
Q4 2017

Feb 12, 2018

BUY
$90.86 - $100.24 $2.22 Million - $2.45 Million
24,488 Added 7.08%
370,468 $36.5 Million
Q3 2017

Oct 31, 2017

BUY
$91.96 - $108.35 $4.05 Million - $4.77 Million
43,996 Added 14.57%
345,980 $32.4 Million
Q2 2017

Aug 09, 2017

BUY
N/A
301,984
301,984 $33.6 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Seizert Capital Partners, LLC Portfolio

Follow Seizert Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.